Tenaris S.A. (T1SS34)
Sao Paulo Exchange · Brazil · prices in BRL · close of 22 Oct 2026
Key indicators
| Last close | BRL 141.16 |
|---|---|
| 52-week range | 92.43 – 163.00 |
| Return, 1 month / 3 months | −2.4% / +0.8% |
| Return, 1 year / 3 years | +58.4% / +88.8% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 42 |
| Volatility (1 year) | 35.5% |
| Worst drawdown (1 year) | -15.1% |
| Average daily value traded | 0.01M BRL |
| Dividend yield | 18.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Tenaris makes steel pipe products, chiefly seamless and welded casing and tubing used in oil and gas wells, along with line pipe and mechanical and structural tubes. Its customers are mainly energy companies that drill and complete wells, plus industrial users such as power plants and machinery makers. The company is based in Luxembourg and runs manufacturing and service operations in many countries, supplying tubular goods and related services to energy markets around the world.
Tenaris S.A. is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code T1SS34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Tenaris S.A. (T1SS34) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 141.16 on 22 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 447 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 58.4% and over the last three months it rose 0.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 61 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.2% | ||
| From 52-week high | -13.4% | ||
| Momentum | 57 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 0.8% | ||
| 6-month return | -6.4% | ||
| 12-month return, skipping the last month | 62.3% | ||
| Stability (higher is calmer) | 70 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 35.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -15.1% | ||
| Liquidity | 21 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M BRL | ||
| Zero-volume days | 65.0% | ||
| Income | 84 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 18.3% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −3.7% |
|---|---|
| 1 month | −2.4% |
| 3 months | +0.8% |
| 6 months | −6.4% |
| 1 year | +58.4% |
| 3 years | +88.8% |
| 5 years | +169.8% |
Signals
| 50-day / 200-day average | 143.05 / 136.84 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.74 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 May 2026 | EUR 3.0338 |
| 24 Nov 2025 | EUR 1.5354 |
| 19 May 2025 | EUR 3.1670 |
| 18 Nov 2024 | EUR 1.6343 |
| 20 May 2024 | EUR 2.0964 |
| 20 Nov 2023 | EUR 0.9903 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.